Jagman,
Terry, "Now you say with a sealed deal and revenues on the horizon that BIPH is "smoke and mirrors." Market doesn't read it that way and insiders aren't loading up, maybe they can't see the horizon.
Biotechs are nothing if not volatile. It is hysterical that most every trader credits a lunatic market with being some kind of omniscient deity while hoping to profit off their superior knowledge despite this Divine Wisdom.
There is currently a river of tears being shed over the "rape" of common shareholder by the loan to BIPH from BioMed controlled by one Mike Weiner.
These screams of insiders not doing enough go beyond ridiculous at times.
The CEO of AGEN personally caused a spike in the stock price by buying $1M+ dollars worth some months ago along with smaller purchases by another exec. With a bedraggled stock settling back to go, some shareholders have asked why won't the CEO buy more.
Best, Terry
News 
Market Data 
Discover 
